Hepatocellular Carcinoma Panel

The Hepatocellular Carcinoma Panel test contains 1 test.

HCC Risk Panel includes serum AFP-L3%, total AFP and DCP. The combined measurement helps discriminate benign and malignant conditions related to primary liver diseases [1-4]. Furthermore, the combination measurement of three HCC biomarkers can identify a greater number of patients at risk of developing HCC than with each marker alone.
  • No Prescription Needed
  • Discounts up to 80%
  • Hundreds of Lab Tests Available

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Search by Zip Code

No Results Found

There are no results that match the search criteria submitted.
Please change the criteria and try again.